CA2264943A1 - Novel methods - Google Patents
Novel methods Download PDFInfo
- Publication number
- CA2264943A1 CA2264943A1 CA002264943A CA2264943A CA2264943A1 CA 2264943 A1 CA2264943 A1 CA 2264943A1 CA 002264943 A CA002264943 A CA 002264943A CA 2264943 A CA2264943 A CA 2264943A CA 2264943 A1 CA2264943 A1 CA 2264943A1
- Authority
- CA
- Canada
- Prior art keywords
- cardiovascular disease
- formula
- compound
- effects
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2543996P | 1996-09-06 | 1996-09-06 | |
| US60/025,439 | 1996-09-06 | ||
| US5066697P | 1997-06-24 | 1997-06-24 | |
| US60/050,666 | 1997-06-24 | ||
| PCT/US1997/015475 WO1998009619A1 (en) | 1996-09-06 | 1997-09-03 | Novel methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2264943A1 true CA2264943A1 (en) | 1998-03-12 |
Family
ID=26699738
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002264943A Abandoned CA2264943A1 (en) | 1996-09-06 | 1997-09-03 | Novel methods |
| CA002264775A Abandoned CA2264775A1 (en) | 1996-09-06 | 1997-09-03 | Method of treating post menopausal diseases, including osteoporosis |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002264775A Abandoned CA2264775A1 (en) | 1996-09-06 | 1997-09-03 | Method of treating post menopausal diseases, including osteoporosis |
Country Status (16)
| Country | Link |
|---|---|
| EP (2) | EP0927029A4 (de) |
| JP (2) | JP2002515046A (de) |
| KR (2) | KR20000068473A (de) |
| CN (2) | CN1236313A (de) |
| AR (1) | AR008155A1 (de) |
| AU (2) | AU4409797A (de) |
| BR (2) | BR9711676A (de) |
| CA (2) | CA2264943A1 (de) |
| CO (2) | CO5070658A1 (de) |
| CZ (1) | CZ76699A3 (de) |
| IL (1) | IL128645A0 (de) |
| NO (2) | NO991097D0 (de) |
| PL (2) | PL332278A1 (de) |
| TR (2) | TR199900506T2 (de) |
| TW (1) | TW411273B (de) |
| WO (2) | WO1998009619A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5749998A (en) * | 1997-02-11 | 1998-08-26 | Novo Nordisk A/S | Methods for treatment or prophylaxis of menopausal symptoms |
| GB9827121D0 (en) * | 1998-12-09 | 1999-02-03 | Orion Corp | Agent for lowering endothelin levels |
| DE19905961A1 (de) * | 1999-02-12 | 2000-08-17 | Stefan Neubauer | Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz |
| US6528681B2 (en) * | 2000-04-05 | 2003-03-04 | Bristol-Meyers Squibb Pharma Company | Halogenated triphenylethylene derivatives as selective estrogen receptor modulators |
| TWI303990B (en) | 2000-10-17 | 2008-12-11 | Pfizer Prod Inc | New use of estrogen agonists/antagonists for improving vascular health |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2196003A (en) * | 1986-09-11 | 1988-04-20 | Nat Res Dev | Iodo-and bromo-tamoxifen derivatives |
| ES2112994T3 (es) * | 1992-09-15 | 1998-04-16 | Merrell Pharma Inc | Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno. |
| US6197789B1 (en) * | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US5681835A (en) * | 1994-04-25 | 1997-10-28 | Glaxo Wellcome Inc. | Non-steroidal ligands for the estrogen receptor |
| US5604248A (en) * | 1994-05-05 | 1997-02-18 | Eli Lilly And Company | Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| US5470883A (en) * | 1994-05-23 | 1995-11-28 | Stromberg; Brent V. | Method of treating peripheral vasoconstriction with tamoxifen citrate |
| HN1996000101A (es) * | 1996-02-28 | 1997-06-26 | Inc Pfizer | Terapia combinada para la osteoporosis |
| US6069175A (en) * | 1996-11-15 | 2000-05-30 | Pfizer Inc. | Estrogen agonist/antagonists treatment of atherosclerosis |
-
1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/es unknown
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/ko not_active Application Discontinuation
- 1997-09-03 BR BR9711676A patent/BR9711676A/pt not_active Application Discontinuation
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/xx unknown
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Application Discontinuation
- 1997-09-03 PL PL97332278A patent/PL332278A1/xx unknown
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-03 JP JP51283798A patent/JP2002515046A/ja active Pending
- 1997-09-03 EP EP97942388A patent/EP0927029A4/de not_active Withdrawn
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Application Discontinuation
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/xx unknown
- 1997-09-03 PL PL97332038A patent/PL332038A1/xx unknown
- 1997-09-03 CN CN97199493A patent/CN1236313A/zh active Pending
- 1997-09-03 JP JP51283898A patent/JP2002515047A/ja active Pending
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 BR BR9711681A patent/BR9711681A/pt not_active Application Discontinuation
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/cs unknown
- 1997-09-03 CN CN97199492A patent/CN1236299A/zh active Pending
- 1997-09-03 IL IL12864597A patent/IL128645A0/xx unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/ko not_active Application Discontinuation
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 EP EP97940773A patent/EP0929216A4/de not_active Withdrawn
- 1997-09-04 CO CO97051289A patent/CO5070658A1/es unknown
- 1997-09-04 CO CO97051287A patent/CO4920218A1/es unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/zh active
-
1999
- 1999-03-05 NO NO991097A patent/NO991097D0/no not_active Application Discontinuation
- 1999-03-05 NO NO991096A patent/NO991096L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW411273B (en) | 2000-11-11 |
| WO1998009619A1 (en) | 1998-03-12 |
| AR008155A1 (es) | 1999-12-09 |
| PL332278A1 (en) | 1999-08-30 |
| JP2002515047A (ja) | 2002-05-21 |
| TR199900504T2 (xx) | 1999-06-21 |
| WO1998009519A1 (en) | 1998-03-12 |
| KR20000068473A (ko) | 2000-11-25 |
| JP2002515046A (ja) | 2002-05-21 |
| CO4920218A1 (es) | 2000-05-29 |
| CO5070658A1 (es) | 2001-08-28 |
| NO991097L (no) | 1999-03-05 |
| CN1236299A (zh) | 1999-11-24 |
| NO991097D0 (no) | 1999-03-05 |
| AU4247397A (en) | 1998-03-26 |
| NO991096D0 (no) | 1999-03-05 |
| BR9711676A (pt) | 1999-08-24 |
| EP0927029A4 (de) | 2001-06-13 |
| NO991096L (no) | 1999-03-05 |
| EP0929216A4 (de) | 2001-04-04 |
| CN1236313A (zh) | 1999-11-24 |
| EP0927029A1 (de) | 1999-07-07 |
| EP0929216A1 (de) | 1999-07-21 |
| CZ76699A3 (cs) | 1999-08-11 |
| CA2264775A1 (en) | 1998-03-12 |
| IL128645A0 (en) | 2000-01-31 |
| PL332038A1 (en) | 1999-08-16 |
| AU4409797A (en) | 1998-03-26 |
| BR9711681A (pt) | 1999-08-24 |
| KR20000068472A (ko) | 2000-11-25 |
| TR199900506T2 (xx) | 1999-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1337591C (en) | Therapeutic composition comprising oestrogen and antioestrogen | |
| KR100278946B1 (ko) | 혈청 콜레스테롤을 저하시키는데 유용한 벤조티오펜 | |
| CA2356158C (en) | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications | |
| CA2609336C (en) | Quadraphasic continuous graduated estrogen contraceptive | |
| AU716249B2 (en) | Contraceptive process and kit for female mammals that consists of a combination of gestagen and estrogen | |
| WO2000038726A1 (en) | Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications | |
| AU2002243411B2 (en) | Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy | |
| NZ262657A (en) | Hormone replacement therapy using estrogen and antiprogestin | |
| WO2000038722A1 (en) | COMBINATIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS AND HMG CoA REDUCTASE INHIBITORS FOR CARDIOVASCULAR INDICATIONS | |
| PH26709A (en) | Compositions and method of selecting contraceptions | |
| NZ210626A (en) | Multi-stage contraceptive combination | |
| CA2264943A1 (en) | Novel methods | |
| CA2268211A1 (en) | Control of selective estrogen receptor modulators | |
| US20020183291A1 (en) | Product for treating gynecomastia | |
| JP2000513331A (ja) | 鬱病の治療におけるパロキセチン | |
| US4956361A (en) | New combination products having an antidepressant action | |
| MXPA99002214A (en) | Novel methods | |
| WO1999000019A1 (en) | Methods of treating the symptoms of atrophic vaginitis and altered sexual behavior in postmenopausal women | |
| WO1999000018A1 (en) | Methods of treating symptoms of impaired memory, concentration and cognition in postmenopausal women | |
| WO1998049896A1 (en) | A method of treating vasomotor symptoms | |
| WO1995008329A1 (en) | Methods for the reduction of postmenopausal ldl cholesterol | |
| NZ244997A (en) | Use of melatonin derivatives for contraception |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |